Cardiovascular variables before intervention, inotropic support required to maintain perfusion, and initial response to interventional embolisation
| Patient | ECG | RV pressure (%)* | RV fractional shortening (%) | Response to initial embolisation | Cardiovascular drugs |
|---|---|---|---|---|---|
| *Expressed as percentage of measured systemic arterial or aortic pressure. | |||||
| ECG, Electrocardiogram; RVH, right ventricular hypertrophy; RBBB, right bundle branch block; RV, right ventricular; MBP, mean arterial blood pressure; SBP, systolic blood pressure; PGE1, prostaglandin E1; SNP, sodium nitroprusside; GTN, glyceryl trinitrate. | |||||
| 1 | Sinus (RVH) | 109 | 26 | ↑ in MBP by 22% | Dopamine, frusemide |
| 2 | Sinus | 50 | 42 | ↑ in SBP by 10% | Dopamine |
| 3 | Sinus tachycardia 200 beats/min, lateral ischaemia | 115 | 44 | Fulminant right heart failure, asystole | Dopamine, noradrenaline, nitric oxide |
| 4 | Sinus RVH, inferior ischaemia | 115 | 19 | ↑ in SBP by 50% | Dopamine, PGE1†, SNP‡ |
| 5 | Sinus tachycardia, 240 beats/min, RBBB | 67 | 39 | ↑ in SBP by 30% | Dopamine, adrenaline, SNP‡, GTN§ |
| 6 | Sinus RVH and ischaemia | 90 | 39 | ↑ in SBP by 30% | Dobutamine, frusemide |
| 7 | Complete heart block,110 beats/min | 118 | 15 | ↑ in SBP by 15% | Dobutamine, SNP‡, GTN§, nitric oxide |
| 8 | Sinus | 65 | 30 | ↑ in SBP by 15% | Milrinone |
| 9 | Sinus tachycardia RVH, lateral ischaemia | 110 | 28 | ↑ in SBP by 15% | Milrinone |